Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1990 Jul;62(1):33–36. doi: 10.1038/bjc.1990.224

The effect of L-dopa on the potentiation of radiation damage to human melanoma cells.

I Yamada 1, S Seki 1, S Ito 1, S Suzuki 1, O Matsubara 1, T Kasuga 1
PMCID: PMC1971730  PMID: 2390479

Abstract

Since L-dopa (L-3,4-dihydroxyphenylalanine) has been shown to possess a selective toxicity for melanoma cells both in vitro and in vivo, we have examined the combined effect of L-dopa and radiation on human melanoma cells. It was found that the combined use of L-dopa potentiated the radiation cytotoxicity to HMV-I human melanoma cells, compared with the response seen in non-melanoma HeLa S3 cells. In HMV-I cells during their exponential phase, L-dopa decreased the shoulder width of the radiation survival curve significantly. In addition, L-dopa significantly inhibited the repair of potentially lethal damage (PLD) in HMV-I cells during their plateau phase. When the distributions of the G1, S, and G2-M cells were measured 24 h after combined L-dopa and radiation treatment, there was significant increase in the accumulation of cells in the G2-M phase of the cell cycle, compared to cells that received either L-dopa or radiation treatment only.

Full text

PDF
33

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barranco S. C., Romsdahl M. M., Humphrey R. M. The radiation response of human malignant melanoma cells grown in vitro. Cancer Res. 1971 Jun;31(6):830–833. [PubMed] [Google Scholar]
  2. Dean P. N. A simplified method of DNA distribution analysis. Cell Tissue Kinet. 1980 May;13(3):299–308. doi: 10.1111/j.1365-2184.1980.tb00468.x. [DOI] [PubMed] [Google Scholar]
  3. Dean P. N., Gray J. W., Dolbeare F. A. The analysis and interpretation of DNA distributions measured by flow cytometry. Cytometry. 1982 Nov;3(3):188–195. doi: 10.1002/cyto.990030309. [DOI] [PubMed] [Google Scholar]
  4. Fertil B., Malaise E. P. Inherent cellular radiosensitivity as a basic concept for human tumor radiotherapy. Int J Radiat Oncol Biol Phys. 1981 May;7(5):621–629. doi: 10.1016/0360-3016(81)90377-1. [DOI] [PubMed] [Google Scholar]
  5. Graham D. G., Tiffany S. M., Vogel F. S. The toxicity of melanin precursors. J Invest Dermatol. 1978 Feb;70(2):113–116. doi: 10.1111/1523-1747.ep12541249. [DOI] [PubMed] [Google Scholar]
  6. Habermalz H. J., Fischer J. J. Radiation therapy of malignant melanoma: experience with high individual treatment doses. Cancer. 1976 Dec;38(6):2258–2262. doi: 10.1002/1097-0142(197612)38:6<2258::aid-cncr2820380611>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  7. Lönn U., Lönn S. Reduced repair of X-ray-induced DNA lesions in cells without functioning DNA polymerase alpha. Radiat Res. 1985 Apr;102(1):71–75. [PubMed] [Google Scholar]
  8. Overgaard J. Radiation treatment of malignant melanoma. Int J Radiat Oncol Biol Phys. 1980 Jan;6(1):41–44. doi: 10.1016/0360-3016(80)90201-1. [DOI] [PubMed] [Google Scholar]
  9. Sasaki T. [Tumor progression and tumor stem cell heterogeneity in relation to tumor radioresistance]. Gan No Rinsho. 1987 Oct;33(13):1560–1569. [PubMed] [Google Scholar]
  10. Weichselbaum R. R., Little J. B. Radioresistance in some human tumor cells conferred in vitro by repair of potentially lethal X-ray damage. Radiology. 1982 Nov;145(2):511–513. doi: 10.1148/radiology.145.2.7134460. [DOI] [PubMed] [Google Scholar]
  11. Weichselbaum R. R., Little J. B. The differential response of human tumours to fractionated radiation may be due to a post-irradiation repair process. Br J Cancer. 1982 Oct;46(4):532–537. doi: 10.1038/bjc.1982.237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Wick M. M., Byers L., Frei E., 3rd L-dopa: selective toxicity for melanoma cells in vitro. Science. 1977 Jul 29;197(4302):468–469. doi: 10.1126/science.877570. [DOI] [PubMed] [Google Scholar]
  13. Wick M. M. Dopamine: a novel antitumor agent active against B-16 melanoma in vivo. J Invest Dermatol. 1978 Aug;71(2):163–164. doi: 10.1111/1523-1747.ep12546959.1. [DOI] [PubMed] [Google Scholar]
  14. Wick M. M. Levodopa and dopamine analogs as DNA polymerase inhibitors and antitumor agents in human melanoma. Cancer Res. 1980 May;40(5):1414–1418. [PubMed] [Google Scholar]
  15. Wick M. M. The chemotherapy of malignant melanoma. J Invest Dermatol. 1983 Jun;80 (Suppl):61s–62s. [PubMed] [Google Scholar]
  16. Yamada I., Seki S., Matsubara O., Ito S., Suzuki S., Kasuga T. The cytotoxicity of cysteinylcatechols and related compounds to human melanoma cells in vitro. J Invest Dermatol. 1987 May;88(5):538–540. doi: 10.1111/1523-1747.ep12470098. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES